Literature DB >> 23703101

Testicular germ cell tumors. Current concepts and management strategies.

N G Cost1.   

Abstract

Testicular germ cell tumors (T-GCTs) are the most common solid tumor in adolescent and young adult men. Due to the success of multidisciplinary management, the prognosis of all stages of T-GCT is quite good. The development of complimentary therapeutic strategies including modern cytotoxic chemotherapy regimens, appropriate utilization of radiotherapy, and timely surgical resection has made T-GCTs the model of a "curative" malignancy. Herein we review the background, epidemiology, and genetics of the disease, as well as an approach to its diagnosis and staging, including rationale for managing T-GCT in its various stages. In summary, while some areas in T-GCT care are debated, the vast majority of patients should be approached in a standardized manner which ensures optimal oncologic outcomes and minimal therapeutic morbidity.

Entities:  

Mesh:

Year:  2013        PMID: 23703101

Source DB:  PubMed          Journal:  Minerva Urol Nefrol        ISSN: 0393-2249            Impact factor:   3.720


  3 in total

1.  TDRG1 regulates chemosensitivity of seminoma TCam-2 cells to cisplatin via PI3K/Akt/mTOR signaling pathway and mitochondria-mediated apoptotic pathway.

Authors:  Yu Gan; Yong Wang; Zhengyu Tan; Jun Zhou; Riko Kitazawa; Xianzhen Jiang; Yuxin Tang; Jianfu Yang
Journal:  Cancer Biol Ther       Date:  2016-04-22       Impact factor: 4.742

2.  Adolescent and young adult cancer survival.

Authors:  Denise Riedel Lewis; Nita L Seibel; Ashley Wilder Smith; Margaret R Stedman
Journal:  J Natl Cancer Inst Monogr       Date:  2014-11

3.  Testis developmental related gene 1 regulates the chemosensitivity of seminoma TCam-2 cells to cisplatin via autophagy.

Authors:  Dongyi Peng; Jingchao Wei; Yu Gan; Jianfu Yang; Xianzhen Jiang; Riko Kitazawa; Yali Xiang; Yingbo Dai; Yuxin Tang
Journal:  J Cell Mol Med       Date:  2019-09-09       Impact factor: 5.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.